| scholarly article | Q13442814 |
| P50 | author | Teresa L Wood | Q87258024 |
| Wendy B Macklin | Q88488355 | ||
| P2093 | author name string | Jinxiang Dai | |
| Jungsoo Min | |||
| Kathryn K. Bercury | |||
| Lauren E. Mursch | |||
| Stacey E. Cifelli | |||
| P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 | ||
| PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase | Q24300915 | ||
| mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery | Q24302549 | ||
| Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia | Q50507092 | ||
| p38 mitogen-activated protein kinase is required for central nervous system myelination | Q50923980 | ||
| Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. | Q50989299 | ||
| The effect of neonatal thyroidectomy on myelination in the rat brain | Q51160395 | ||
| Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death | Q51890411 | ||
| Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs | Q52041786 | ||
| The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways | Q52195728 | ||
| Effects of Thyroid Hormone on Embryonic Oligodendrocyte Precursor Cell Developmentin Vivoandin Vitro | Q52197176 | ||
| Investigations on myelination in vitro. Regulation of sulfolipid synthesis by thyroid hormone in cultures of dissociated brain cells from embryonic mice. | Q52294538 | ||
| Akt-mediated survival of oligodendrocytes induced by neuregulins. | Q55475068 | ||
| Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium | Q71129244 | ||
| In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice | Q71511581 | ||
| A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation | Q39372532 | ||
| mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. | Q39616865 | ||
| mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling | Q39765614 | ||
| Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells. | Q40172304 | ||
| Functional genomics identifies TOR-regulated genes that control growth and division | Q40277449 | ||
| regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis | Q40499939 | ||
| Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors | Q40768915 | ||
| Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon | Q40915855 | ||
| Neuregulins in development | Q40943947 | ||
| Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation | Q40989063 | ||
| Insulin-like growth factor I regulates G2/M progression through mammalian target of rapamycin signaling in oligodendrocyte progenitors. | Q41035104 | ||
| Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells | Q41108824 | ||
| The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
| Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease | Q41157691 | ||
| PI3K: downstream AKTion blocks apoptosis | Q41351876 | ||
| Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. | Q41880723 | ||
| mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis | Q41910369 | ||
| Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways | Q42099912 | ||
| Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons | Q42484843 | ||
| The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. | Q42591243 | ||
| Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. | Q42810841 | ||
| Regulation of adipocyte differentiation and insulin action with rapamycin. | Q42825624 | ||
| Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. | Q42997819 | ||
| Initiation of neuronal differentiation requires PI3-kinase/TOR signalling in the vertebrate neural tube | Q43224792 | ||
| Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches | Q43581929 | ||
| IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle | Q43636472 | ||
| Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis | Q44078368 | ||
| Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains | Q44290613 | ||
| IGF-I and NT-3 signaling pathways in developing oligodendrocytes: differential regulation and activation of receptors and the downstream effector Akt. | Q44383868 | ||
| Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. | Q44684981 | ||
| IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors | Q44813370 | ||
| Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study | Q44839318 | ||
| Investigations on myelination in vitro. Regulation by thyroid hormone in cultures of dissociated brain cells from embryonic mice | Q45168538 | ||
| IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. | Q46005419 | ||
| The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. | Q46021705 | ||
| High cholesterol level is essential for myelin membrane growth | Q46406733 | ||
| Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. | Q46541111 | ||
| Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway | Q46709267 | ||
| Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex. | Q46983617 | ||
| Temporal control of differentiation by the insulin receptor/tor pathway in Drosophila | Q47070849 | ||
| IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells | Q47920201 | ||
| GGF/neuregulin induces a phenotypic reversion of oligodendrocytes | Q48245409 | ||
| A central role for RhoA during oligodendroglial maturation in the switch from netrin-1-mediated chemorepulsion to process elaboration | Q48248550 | ||
| IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases | Q48248963 | ||
| Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice | Q48313440 | ||
| Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment | Q48373791 | ||
| Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex | Q48522540 | ||
| Myelination is altered in insulin-like growth factor-I null mutant mice. | Q48546118 | ||
| The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. | Q48546876 | ||
| Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain | Q48612039 | ||
| GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors | Q48956089 | ||
| Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action | Q24302566 | ||
| Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells | Q24303535 | ||
| Identification of Protor as a novel Rictor-binding component of mTOR complex-2 | Q24303936 | ||
| Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive | Q24306328 | ||
| SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth | Q24309283 | ||
| mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1 | Q24319851 | ||
| Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling | Q24323370 | ||
| Identification of a proline-rich Akt substrate as a 14-3-3 binding partner | Q24338582 | ||
| Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. | Q24540159 | ||
| Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism | Q24608263 | ||
| The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation | Q24616946 | ||
| Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer | Q24617184 | ||
| Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy | Q24632296 | ||
| Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine | Q24633679 | ||
| Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1 | Q24645183 | ||
| mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice | Q24658113 | ||
| Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity | Q24680264 | ||
| Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice | Q27324246 | ||
| TOR signaling in growth and metabolism | Q27860757 | ||
| GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR | Q28115142 | ||
| A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells | Q28141706 | ||
| Type III neuregulin-1 promotes oligodendrocyte myelination | Q28261097 | ||
| The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination | Q28261757 | ||
| Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1 | Q28276788 | ||
| Molecular and cellular aspects of the insulin-like growth factor I receptor | Q28288023 | ||
| Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size | Q28304000 | ||
| Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 | ||
| Axonal neuregulin-1 regulates myelin sheath thickness | Q28504655 | ||
| Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings | Q28505437 | ||
| A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development | Q28507109 | ||
| Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney | Q28507177 | ||
| A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development | Q72048609 | ||
| Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells | Q73131749 | ||
| Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage | Q73650552 | ||
| Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity | Q73870801 | ||
| Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord | Q78424874 | ||
| p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target | Q79604064 | ||
| Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway | Q80233774 | ||
| Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways | Q80348606 | ||
| Oligodendrocyte maturation is inhibited by bone morphogenetic protein | Q80382762 | ||
| Severe impairment of cerebellum development in mice expressing a dominant-negative mutation inactivating thyroid hormone receptor alpha1 isoform | Q84215036 | ||
| Wnt signaling is sufficient to perturb oligodendrocyte maturation | Q84260240 | ||
| Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2 | Q34286779 | ||
| The oligodendrocyte and its many cellular processes | Q34290907 | ||
| Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 | ||
| TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity | Q34598209 | ||
| Rheb1 is required for mTORC1 and myelination in postnatal brain development | Q34665970 | ||
| An 'oligarchy' rules neural development | Q34750265 | ||
| Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation | Q34762309 | ||
| The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. | Q34774397 | ||
| Regulation of oligodendrocyte development in the vertebrate CNS. | Q34973857 | ||
| Molecular crosstalk between p70S6k and MAPK cell signaling pathways | Q34975063 | ||
| Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination | Q35126078 | ||
| Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination | Q35132066 | ||
| Canonical Wnt Signalling Requires the BMP Pathway to Inhibit Oligodendrocyte Maturation | Q35161679 | ||
| The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. | Q35216878 | ||
| Constitutively active Akt induces enhanced myelination in the CNS | Q35394901 | ||
| YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells | Q35513380 | ||
| Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex | Q35546651 | ||
| The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2. | Q35562825 | ||
| Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development | Q35589345 | ||
| Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination | Q35597565 | ||
| TOR in the immune system | Q35621941 | ||
| Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation | Q35693398 | ||
| Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation | Q28511485 | ||
| Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation | Q28568907 | ||
| A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development | Q28579332 | ||
| The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C | Q28587901 | ||
| Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation | Q28588209 | ||
| Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS | Q28589814 | ||
| Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination | Q28591752 | ||
| HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction | Q28593397 | ||
| Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection | Q28594759 | ||
| Regulation of Oligodendrocyte Differentiation and Myelination | Q29542652 | ||
| Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
| An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 | Q29614563 | ||
| Activation of a metabolic gene regulatory network downstream of mTOR complex 1 | Q29615179 | ||
| Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue | Q29615225 | ||
| Growing roles for the mTOR pathway | Q29616212 | ||
| Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 | Q29617097 | ||
| mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex | Q29617214 | ||
| The nuts and bolts of AGC protein kinases | Q29617465 | ||
| The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 | ||
| mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway | Q30425628 | ||
| Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins | Q30438876 | ||
| Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity | Q30442556 | ||
| Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex | Q30529898 | ||
| Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy | Q33589972 | ||
| A bimodal influence of thyroid hormone on cerebellum oligodendrocyte differentiation. | Q33636657 | ||
| Two-tier transcriptional control of oligodendrocyte differentiation | Q33677363 | ||
| mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action | Q33706924 | ||
| Oligodendrocyte development and thyroid hormone. | Q33714940 | ||
| Insulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes | Q33910877 | ||
| Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. | Q33959870 | ||
| mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. | Q33973841 | ||
| Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation | Q34000315 | ||
| Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway | Q34077087 | ||
| Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes | Q34130047 | ||
| Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination | Q34253257 | ||
| The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation | Q34283579 | ||
| Glial specification in the vertebrate neural tube | Q35752440 | ||
| Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage. | Q35771238 | ||
| Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics | Q35879915 | ||
| Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase | Q35892864 | ||
| Integrin-growth factor interactions as regulators of oligodendroglial development and function | Q35971762 | ||
| mTORC1 is essential for leukemia propagation but not stem cell self-renewal | Q36005418 | ||
| A Critical Role for Rictor in T Lymphopoiesis | Q36141169 | ||
| Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. | Q36274058 | ||
| ERK1/ERK2 MAPK Signaling is Required to Increase Myelin Thickness Independent of Oligodendrocyte Differentiation and Initiation of Myelination | Q36464562 | ||
| Olig gene function in CNS development and disease | Q36465466 | ||
| The amino acid sensitive TOR pathway from yeast to mammals. | Q36473396 | ||
| Defining Akt actions in muscle differentiation. | Q36494504 | ||
| Axonal regulation of myelination by neuregulin 1. | Q36589639 | ||
| The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation | Q36600067 | ||
| Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase | Q36623662 | ||
| Integration of nutritional and stress signaling pathways by Maf1. | Q36686250 | ||
| The TSC1-TSC2 complex is required for proper activation of mTOR complex 2 | Q36710799 | ||
| p38 Mitogen-activated protein kinase regulates myelination | Q36997755 | ||
| Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. | Q37066557 | ||
| A matter of identity: transcriptional control in oligodendrocytes | Q37134194 | ||
| The mTOR signaling network: insights from its role during embryonic development | Q37160816 | ||
| The Yin and Yang of YY1 in the nervous system | Q37165666 | ||
| Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells | Q37344179 | ||
| Developmental profiles of lipogenic enzymes and their regulators in the neonatal mouse brain | Q37352030 | ||
| Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. | Q37376549 | ||
| Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. | Q37377107 | ||
| An emerging role of mTOR in lipid biosynthesis. | Q37641438 | ||
| Transcriptional and post-transcriptional control of CNS myelination | Q37765990 | ||
| Nrg1/ErbB signaling networks in Schwann cell development and myelination | Q37787450 | ||
| Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis | Q37856368 | ||
| Glia unglued: How signals from the extracellular matrix regulate the development of myelinating glia | Q37915435 | ||
| ID2: A negative transcription factor regulating oligodendroglia differentiation | Q37976660 | ||
| The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. | Q37996420 | ||
| A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor. | Q38308944 | ||
| Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter | Q38326873 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regulation of gene expression | Q411391 |
| oligodendrocyte | Q916698 | ||
| nervous system | Q9404 | ||
| cell | Q7868 | ||
| developmental gene expression regulation | Q70697639 | ||
| serine/threonine-protein kinase TOR | Q24723029 | ||
| enzyme | Q8047 | ||
| P304 | page(s) | e00108 | |
| P577 | publication date | 2013-03-19 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | ASN Neuro | Q20312578 |
| P1476 | title | mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development | |
| mTOR: A Link from the Extracellular Milieu to Transcriptional Regulation of Oligodendrocyte Development | |||
| P478 | volume | 5 |
| Q41211684 | A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model |
| Q33631202 | A mutation in the canine gene encoding folliculin-interacting protein 2 (FNIP2) associated with a unique disruption in spinal cord myelination |
| Q38122225 | Akt/mTOR signalling in myelination |
| Q55073612 | Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. |
| Q35202359 | CNS myelination requires cytoplasmic dynein function |
| Q36480281 | Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice. |
| Q88188972 | Clemastine effects in rat models of a myelination disorder |
| Q35594174 | Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes |
| Q41560440 | Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system |
| Q98772165 | EED-mediated histone methylation is critical for CNS myelination and remyelination by inhibiting WNT, BMP, and senescence pathways |
| Q36254079 | Fbxw7 Limits Myelination by Inhibiting mTOR Signaling. |
| Q35559678 | Gas6 enhances axonal ensheathment by MBP+ membranous processes in human DRG/OL promyelinating co-cultures |
| Q40413443 | Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex. |
| Q91564490 | Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood |
| Q37592138 | Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle |
| Q47687993 | Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis. |
| Q38766318 | Intracellular signaling pathway regulation of myelination and remyelination in the CNS. |
| Q26744655 | Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function |
| Q37663142 | Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. |
| Q30355283 | Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. |
| Q36339174 | Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development |
| Q35707945 | Olig1 function is required for oligodendrocyte differentiation in the mouse brain |
| Q28508935 | Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain |
| Q37127817 | Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. |
| Q49815600 | PTEN negatively regulates the cell lineage progression from NG2+ glial progenitor to oligodendrocyte via mTOR-independent signaling. |
| Q48272328 | Schwann cell-specific deletion of the endosomal PI 3-kinase Vps34 leads to delayed radial sorting of axons, arrested myelination, and abnormal ErbB2-ErbB3 tyrosine kinase signaling. |
| Q38943983 | Serine/threonine-protein kinase PFTK1 modulates oligodendrocyte differentiation via PI3K/AKT pathway |
| Q90021339 | Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis |
| Q31162298 | Structures Showing Negative Correlations of Signal Intensity with Postnatal Age on T1-weighted Imaging of the Brain of Newborns and Infants |
| Q41157649 | The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/β-catenin signaling. |
| Q38705961 | Transcription factor 7 like 2 promotes oligodendrocyte differentiation and remyelination |
| Q35625755 | Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain |
| Q35035474 | mTOR kinase: a possible pharmacological target in the management of chronic pain |
Search more.